Vanguard Group’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22.9M Buy
3,584,213
+370,210
+12% +$2.36M ﹤0.01% 2498
2025
Q1
$15.6M Buy
3,214,003
+13,303
+0.4% +$64.7K ﹤0.01% 2621
2024
Q4
$30.6M Sell
3,200,700
-196,926
-6% -$1.88M ﹤0.01% 2381
2024
Q3
$28.4M Sell
3,397,626
-268,608
-7% -$2.24M ﹤0.01% 2420
2024
Q2
$25M Buy
3,666,234
+254,685
+7% +$1.74M ﹤0.01% 2456
2024
Q1
$8.63M Buy
3,411,549
+436,911
+15% +$1.11M ﹤0.01% 3044
2023
Q4
$7.14M Buy
2,974,638
+328,272
+12% +$788K ﹤0.01% 3135
2023
Q3
$9M Sell
2,646,366
-1,695,976
-39% -$5.77M ﹤0.01% 2942
2023
Q2
$31.9M Sell
4,342,342
-1,090,283
-20% -$8.01M ﹤0.01% 2388
2023
Q1
$56.3M Buy
5,432,625
+26,351
+0.5% +$273K ﹤0.01% 2121
2022
Q4
$63.8M Buy
5,406,274
+214,788
+4% +$2.54M ﹤0.01% 2050
2022
Q3
$109M Buy
5,191,486
+101,059
+2% +$2.12M ﹤0.01% 1737
2022
Q2
$158M Sell
5,090,427
-65,954
-1% -$2.05M ﹤0.01% 1567
2022
Q1
$212M Sell
5,156,381
-205,650
-4% -$8.44M 0.01% 1519
2021
Q4
$233M Buy
5,362,031
+440,316
+9% +$19.1M 0.01% 1503
2021
Q3
$246M Sell
4,921,715
-37,332
-0.8% -$1.87M 0.01% 1469
2021
Q2
$312M Buy
4,959,047
+25,077
+0.5% +$1.58M 0.01% 1323
2021
Q1
$458M Buy
4,933,970
+143,397
+3% +$13.3M 0.01% 1007
2020
Q4
$429M Buy
4,790,573
+371,712
+8% +$33.3M 0.01% 960
2020
Q3
$457M Sell
4,418,861
-330,735
-7% -$34.2M 0.02% 814
2020
Q2
$376M Buy
4,749,596
+10,190
+0.2% +$806K 0.01% 893
2020
Q1
$274M Buy
4,739,406
+72,160
+2% +$4.18M 0.01% 945
2019
Q4
$252M Buy
4,667,246
+9,170
+0.2% +$495K 0.01% 1253
2019
Q3
$244M Buy
4,658,076
+47,809
+1% +$2.5M 0.01% 1212
2019
Q2
$223M Sell
4,610,267
-94,080
-2% -$4.55M 0.01% 1290
2019
Q1
$238M Sell
4,704,347
-127,954
-3% -$6.46M 0.01% 1235
2018
Q4
$286M Buy
4,832,301
+229,092
+5% +$13.6M 0.01% 1019
2018
Q3
$303M Buy
4,603,209
+288,252
+7% +$19M 0.01% 1106
2018
Q2
$218M Buy
4,314,957
+157,607
+4% +$7.96M 0.01% 1286
2018
Q1
$219M Buy
4,157,350
+560,115
+16% +$29.5M 0.01% 1227
2017
Q4
$167M Sell
3,597,235
-5,975
-0.2% -$278K 0.01% 1422
2017
Q3
$146M Buy
3,603,210
+50,518
+1% +$2.04M 0.01% 1481
2017
Q2
$120M Sell
3,552,692
-220,508
-6% -$7.48M 0.01% 1568
2017
Q1
$110M Buy
3,773,200
+238,194
+7% +$6.92M 0.01% 1604
2016
Q4
$116M Sell
3,535,006
-143,162
-4% -$4.7M 0.01% 1528
2016
Q3
$116M Buy
3,678,168
+68,036
+2% +$2.15M 0.01% 1469
2016
Q2
$102M Buy
3,610,132
+415,470
+13% +$11.7M 0.01% 1509
2016
Q1
$116M Buy
3,194,662
+306,573
+11% +$11.1M 0.01% 1386
2015
Q4
$116M Buy
2,888,089
+559,059
+24% +$22.4M 0.01% 1363
2015
Q3
$66.4M Buy
2,329,030
+104,086
+5% +$2.97M ﹤0.01% 1715
2015
Q2
$73.3M Buy
2,224,944
+77,759
+4% +$2.56M 0.01% 1734
2015
Q1
$61.8M Buy
2,147,185
+90,099
+4% +$2.59M ﹤0.01% 1809
2014
Q4
$56M Buy
2,057,086
+15,244
+0.7% +$415K ﹤0.01% 1775
2014
Q3
$43.5M Buy
2,041,842
+25,256
+1% +$538K ﹤0.01% 1877
2014
Q2
$45.3M Buy
2,016,586
+38,055
+2% +$855K ﹤0.01% 1888
2014
Q1
$50M Buy
1,978,531
+134,542
+7% +$3.4M ﹤0.01% 1808
2013
Q4
$42.4M Buy
1,843,989
+93,178
+5% +$2.14M ﹤0.01% 1866
2013
Q3
$33.4M Buy
1,750,811
+53,588
+3% +$1.02M ﹤0.01% 1929
2013
Q2
$24.5M Buy
+1,697,223
New +$24.5M ﹤0.01% 2001